GREENLAND MINES LTD Sale of Stock, Price Per Share
GREENLAND MINES LTD (GRML) had Sale of Stock, Price Per Share of $0.26 per share as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2026-08-17
- 2026-06-30: Sale of Stock, Price Per Share $0.26.
- 2024-12-31: Sale of Stock, Price Per Share $0.25.
- 2024-03-31: Sale of Stock, Price Per Share $10.10.
- 2023-12-31: Sale of Stock, Price Per Share $10.10.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2026-06-30 | $0.26 10-Q · filed 2026-08-17 |
| 2024-12-31 | $0.25 10-K · filed 2025-03-31 |
| 2024-03-31 | $10.10 10-Q · filed 2024-05-23 |
| 2023-12-31 | $10.10 10-K · filed 2024-04-17 |
| 2023-09-30 | $10.10 10-Q · filed 2023-11-17 |
| 2023-06-30 | $10.10 10-Q · filed 2023-08-21 |
| 2023-03-31 | $10.10 10-Q · filed 2023-05-24 |
| 2022-12-31 | $10.10 10-K/A · filed 2023-10-18 |
| 2022-09-30 | $10.10 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.10 10-Q · filed 2022-08-15 |
| 2022-04-07 | $10.00 10-Q · filed 2024-05-23 |
| 2022-04-04 | $10.00 10-Q · filed 2024-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |